Cell line · CVCL_0103
SUP-B15
Cancer cell line, Homo sapiens. Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1. 33 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. SUP-B15. Cell lines, record CVCL_0103. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0103
On this page
Cell line
As Cellosaurus gives it.
- Name
- SUP-B15
- Accession
- CVCL_0103
- RRID
- RRID:CVCL_0103
- Synonyms
- Sup-B15, SUPB-15, SUPB15, SupB15, SupB15W, SupB15WT
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 9Y
- Category
- Cancer cell line
- Diseases
- Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1 (NCIt C68659); B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2) (ORDO Orphanet_585909)
- Derived from
- Bone marrow (in situ)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers33
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting Drugs. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Depletion of Tregs from CD4+ CAR-T cells enhances the tumoricidal effect of CD8+ CAR-T cells in anti-CD19 CAR-T therapy. | FEBS J | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Novel immunotherapeutics against LGR5 to target multiple cancer types. | EMBO Mol Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1. | J Immunother Cancer | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Epigenomic mapping reveals distinct B cell acute lymphoblastic leukemia chromatin architectures and regulators. | Cell Genom | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Trypanosoma cruzi Antigenic Proteins Shared with Acute Lymphoblastic Leukemia and Neuroblastoma. | Pharmaceuticals (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylation. | Elife | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Low Prevalence of ETV6::RUNX1 Fusion Gene in a Hispanic Population. | Front Pediatr | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. | Nat Commun | 2022 | Cellosaurus cites it | PubMed |
1 to 10 of 33
See all 33 papersRelatives3
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | SUP-B15/RI | CVCL_S642 | Cell lines | |
| Derived from it | SupB15RT | CVCL_DR65 | Cell lines | |
| From the same person | SUP-B13 | CVCL_A308 | Cell lines |
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-1929 | ATCC | |
| AddexBio | C0003019/4892 | Discontinued | Cellosaurus |
| BCRJ | 0229 | Discontinued | Cellosaurus |
| DSMZ | ACC-389 | DSMZ | |
| IZSLER | BS TCL 238 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0103
GET https://conductscience.org/api/cell-lines/v1/CVCL_0103/papers?page=2